STRIPPOLI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 17.560
AS - Asia 6.342
EU - Europa 3.327
SA - Sud America 2.235
AF - Africa 349
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 7
Totale 29.847
Nazione #
US - Stati Uniti d'America 17.377
SG - Singapore 2.704
BR - Brasile 1.819
CN - Cina 1.235
RU - Federazione Russa 1.096
HK - Hong Kong 964
SE - Svezia 482
VN - Vietnam 425
FR - Francia 321
DE - Germania 264
GB - Regno Unito 263
IT - Italia 205
FI - Finlandia 202
IN - India 193
AR - Argentina 157
BD - Bangladesh 129
CI - Costa d'Avorio 120
UA - Ucraina 108
IQ - Iraq 103
ID - Indonesia 90
ZA - Sudafrica 69
EC - Ecuador 68
MX - Messico 66
PK - Pakistan 59
TR - Turchia 59
CA - Canada 58
BE - Belgio 56
CO - Colombia 55
JP - Giappone 50
NL - Olanda 50
SA - Arabia Saudita 45
AT - Austria 40
MA - Marocco 40
PH - Filippine 38
ES - Italia 36
VE - Venezuela 36
PY - Paraguay 35
UZ - Uzbekistan 35
IE - Irlanda 31
CL - Cile 30
EG - Egitto 28
PL - Polonia 27
EE - Estonia 24
IL - Israele 24
AU - Australia 23
JO - Giordania 21
MY - Malesia 21
KE - Kenya 16
NP - Nepal 15
TH - Thailandia 15
OM - Oman 14
PE - Perù 14
TN - Tunisia 14
BO - Bolivia 13
ET - Etiopia 13
PA - Panama 13
DZ - Algeria 12
JM - Giamaica 12
LT - Lituania 12
PT - Portogallo 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 10
RS - Serbia 10
HU - Ungheria 9
LB - Libano 9
AZ - Azerbaigian 8
KZ - Kazakistan 8
PS - Palestinian Territory 8
RO - Romania 8
UY - Uruguay 8
BH - Bahrain 7
CH - Svizzera 7
CR - Costa Rica 7
GE - Georgia 7
SN - Senegal 7
TW - Taiwan 7
BG - Bulgaria 6
NG - Nigeria 6
XK - ???statistics.table.value.countryCode.XK??? 6
AL - Albania 5
AM - Armenia 5
BB - Barbados 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
KR - Corea 5
MD - Moldavia 5
MK - Macedonia 5
MN - Mongolia 5
SK - Slovacchia (Repubblica Slovacca) 5
AO - Angola 4
IR - Iran 4
KW - Kuwait 4
ME - Montenegro 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
BN - Brunei Darussalam 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
KH - Cambogia 3
Totale 29.794
Città #
Fairfield 2.696
Ashburn 1.782
Singapore 1.555
Chandler 1.530
Woodbridge 1.364
Houston 1.179
Seattle 1.140
Cambridge 1.123
Hong Kong 954
Wilmington 879
San Jose 618
Beijing 430
Ann Arbor 409
Nyköping 383
Lawrence 299
Roxbury 294
Lauterbourg 252
Des Moines 215
Jacksonville 207
Dallas 188
New York 182
Ho Chi Minh City 155
Los Angeles 149
Helsinki 140
São Paulo 123
Abidjan 120
San Diego 115
Inglewood 106
Santa Clara 99
Dearborn 98
The Dalles 94
Council Bluffs 87
Hanoi 87
Columbus 86
Nanjing 75
Buffalo 71
Munich 59
Rio de Janeiro 58
Brussels 56
Chicago 56
London 56
Falls Church 46
Baghdad 45
Tokyo 45
Washington 45
Brooklyn 43
Frankfurt am Main 42
Belo Horizonte 41
Nuremberg 40
Boardman 37
Moscow 36
Pune 36
Johannesburg 34
Dhaka 33
Guayaquil 33
Jakarta 33
Bari 32
Tashkent 32
Dublin 31
Guangzhou 31
Hefei 31
Paris 30
Porto Alegre 30
Salvador 27
Stockholm 27
Princeton 26
Curitiba 25
Edinburgh 25
Guarulhos 24
San Francisco 24
Atlanta 23
Shanghai 23
Amsterdam 22
Kunming 22
Shenzhen 22
Brasília 21
Lahore 21
Turku 21
Vienna 21
Warsaw 21
Hebei 20
Jinan 20
Medellín 20
Riyadh 20
Changsha 19
Haiphong 19
Nanchang 19
Amman 18
Asunción 17
Chennai 17
Denver 17
Goiânia 17
Mexico City 17
Redwood City 17
Ribeirão Preto 17
Boston 16
Campinas 16
Jiaxing 16
Kilburn 16
Milan 16
Totale 21.124
Nome #
The usefulness of Cochrane systematic reviews in nephrology 694
A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study 222
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial 212
Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials 190
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop 189
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 184
An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism 176
Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease 166
Catheter-related interventions to prevent peritonitis in peritoneal dialysis: A systematic review of randomized, controlled trials 155
Aldosterone antagonists for preventing the progression of chronic kidney disease 154
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease 153
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis 153
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials 147
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 145
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis 144
Antiplatelet agents for chronic kidney disease 144
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 144
Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study 141
HMG CoA reductase inhibitors (statins) for kidney transplant recipients 140
Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studies 140
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials 137
Antihypertensive agents for preventing diabetic kidney disease 136
Aldosterone antagonists for preventing the progression of chronic kidney disease 135
Thyroid hormones for acute kidney injury 135
Primary cerebral lymphoma and membranous nephropathy: a still unreported association 134
Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: A population-based longitudinal cohort study 132
Risk of death following kidney allograft failure: A systematic review and meta-analysis of cohort studies 131
Induction and maintenance treatment of proliferative lupus nephritis: A meta-analysis of randomized controlled trials 130
Oral mucosal lesions and risk of all-cause and cardiovascular mortality in people treated with long-term haemodialysis: The ORAL-D multinational cohort study 129
Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials 127
Patient satisfaction with in-centre haemodialysis care: An International Survey 126
Associations between hemodialysis access type and clinical outcomes: A systematic review 126
A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate 124
Proteinuria: Does vitamin D treatment improve outcomes in CKD? 124
Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials 123
Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease 123
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir 121
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease 121
Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy 120
Clinician beliefs and attitudes about home haemodialysis: A multinational interview study 120
Prevalence and Correlates of Self-Reported Sexual Dysfunction in CKD: A Meta-analysis of Observational Studies 120
Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need 120
Quality of reporting of randomization methodology in nephrology trials 120
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: A systematic review and meta-analysis 119
How to read critically a prognostic cohort study 118
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review 116
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: A network meta-analysis 115
Treatment for peritoneal dialysis-associated peritonitis 114
PERIODONTITIS AND RISK OF ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN ADULTS WITH END-STAGE KIDNEY DISEASE: A PROPENSITY-MATCHED STUDY 113
Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials 113
Analysis of the factors which affect renal survival in IgA nephropathy: A cohort study 113
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients 113
IgA Nephropathy: A Disease in Search of a Large-Scale Clinical Trial to Reliably Inform Practice 113
Vitamin D compounds for people with chronic kidney disease requiring dialysis 112
A nephrology guide to reading and using systematic reviews of observational studies 111
Glucose targets for preventing diabetic kidney disease and its progression 111
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients 111
Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis 110
Biocompatible dialysis fluids for peritoneal dialysis 110
HMG CoA reductase inhibitors (statins) for dialysis patients 109
Serum testosterone levels and clinical outcomes in male hemodialysis patients 109
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients 109
Immunosuppressive treatments for immunoglobulin A nephropathy: A meta-analysis of randomized controlled trials 108
Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial 108
Immunosuppressive agents for treating IgA nephropathy 108
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 107
Darbepoetin for the anaemia of chronic kidney disease 107
Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials 107
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials 106
A population-based cohort study defines prognoses in severe chronic kidney disease 106
Home versus in-centre haemodialysis for end-stage kidney disease 105
Pre-emptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients 105
Non-immunosuppressive treatment for IgA nephropathy 105
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials 105
Current structure and organization for renal patient assistance in Italy 104
Sunset for Statins after AURORA? 104
The Italian experience of the national registry of renal biopsies 104
KHA-CARI commentary on the KDIGO clinical practice guideline for lipid management in chronic kidney disease 104
Meta-analysis: Vitamin D compounds in chronic kidney disease 104
Cardiac Rehabilitation Programs for Chronic Heart Disease: A Bayesian Network Meta-analysis 104
[Census of the renal and dialysis units by Italian Society of Nephrology: structure and organization for renal patient assistance in Italy (2014-2015)] 104
Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study. 103
Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. 103
Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO) 103
Convective versus diffusive dialysis therapies for chronic kidney failure: An updated systematic review of randomized controlled trials 103
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease 102
Interventions for minimal change disease in adults with nephrotic syndrome 102
Antihypertensive agents for preventing diabetic kidney disease 102
HMG CoA reductase inhibitors (statins) for kidney transplant recipients 102
The beliefs and expectations of patients and caregivers about home haemodialysis: An interview study 101
Potassium binders for chronic hyperkalaemia in people with chronic kidney disease 101
Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis 100
Sexual Dysfunction in Women with ESRD Requiring Hemodialysis 99
Patients' perspectives on hemodialysis vascular access: A systematic review of qualitative studies 99
A meta-analysis of randomised controlled trials (RCT) comparing extracorporeal renal replacement therapy (RRT) modalities 99
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD) 99
Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials 99
Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: A cross-sectional analytic study 98
Proteinuria and Clinical Outcomes in Hypertensive Patients 98
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis 98
Totale 12.762
Categoria #
all - tutte 126.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021771 0 0 0 0 0 0 0 0 0 434 149 188
2021/20222.410 186 357 20 80 112 152 116 88 124 115 185 875
2022/20233.106 443 347 277 304 273 329 25 440 454 21 138 55
2023/20241.117 84 186 77 28 103 304 30 126 18 28 16 117
2024/20254.545 44 73 394 171 182 427 296 331 272 293 720 1.342
2025/20268.850 1.357 284 690 1.084 964 448 1.304 439 1.518 762 0 0
Totale 30.447